- Weekly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * please note, updates will be limited during August
- Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
- First published
- 22 Dec 2020
- Last updated
- 02 Aug 2021
OpenSAFELY COVID Vaccine coverage report¶
OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.
This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.
The full analytical methods behind the latest results in this report are available here.
- Summary Charts
- Trends in vaccination coverage according to demographic/clinical features, for:
- Current vaccination coverage of each eligible population group, according to demographic/clinical features
- Appendix: Proportion of each population group for whom ethnicity is known
|first dose as at 28 Jul 2021||second dose as at 28 Jul 2021|
|Total vaccinated in TPP||15,587,754||12,771,794|
|80+||96.4% (1,056,748 of 1,096,578)||94.9% (1,040,956 of 1,096,578)|
|70-79||95.9% (1,980,090 of 2,064,062)||94.7% (1,955,002 of 2,064,062)|
|care home||96.1% (83,062 of 86,429)||92.3% (79,800 of 86,429)|
|shielding (aged 16-69)||90.2% (752,857 of 835,072)||85.7% (715,981 of 835,072)|
|65-69||93.4% (1,002,834 of 1,073,338)||91.9% (986,426 of 1,073,338)|
|LD (aged 16-64)||86.0% (71,211 of 82,789)||79.1% (65,471 of 82,789)|
|60-64||91.6% (1,172,556 of 1,279,761)||89.5% (1,145,984 of 1,279,761)|
|55-59||89.7% (1,359,232 of 1,514,751)||87.0% (1,318,051 of 1,514,751)|
|50-54||87.3% (1,368,486 of 1,567,027)||83.8% (1,312,990 of 1,567,027)|
|40-49||79.3% (2,346,568 of 2,960,818)||69.7% (2,064,776 of 2,960,818)|
|30-39||67.2% (2,240,343 of 3,331,958)||40.7% (1,357,587 of 3,331,958)|
|18-29||61.9% (2,153,760 of 3,478,972)||20.9% (728,784 of 3,478,972)|
- The care home group is defined based on patients (aged 65+) having one of these codes.
The LD (learning disability) group is defined based on this codelist and excludes people who are shielding.
Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 population
Oxford-AZ vaccines (% of all first doses): 54.0% (8,413,958)
Pfizer vaccines (% of all first doses): 43.7% (6,805,379)
Moderna vaccines (% of all first doses): 2.4% (373,373)
Second doses and dose combinations¶
Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report
Second doses (% of all vaccinated): 81.9% (12,771,794)
Second doses (% of Ox-AZ first doses): 95.8% (8,063,909)
Second doses (% of Pfizer first doses): 67.6% (4,598,237)
Second doses (% of Moderna first doses): 30.7% (114,702)
Note: mixed doses counts patients with two doses at least 19 days apart, excluding patients with two different brands recorded on the same day or where the first dose was recorded on a date prior to when the given brand was available in the UK
Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.3% (35336)
Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.0% (1575)
Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.0% (1260)
Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.